FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental ophthalmology, and can be used to simulate neurodegenerative processes in the eye. For this, an intravitreal injection of the neurotoxin 6-OHDA to the rabbit in a solution of 0.9% sodium chloride containing ascorbic acid at a concentration of 0.5% is carried out. At the same time, 6-OHDA is administered twice with an interval of 2 hours, 100 mcg in a solution of 50 mcl.
EFFECT: invention provides a well-reproducible and reversible neurodegenerative process in the eye of a rabbit.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXPERIMENTAL TREATMENT OF EYE NEURODEGENERATIVE PROCESS | 2023 |
|
RU2794835C1 |
| METHOD FOR PREDICTION OF DEVELOPING NEURODEGENERATIVE DISEASES, UNDERLYING THE PATHOGENESIS OF WHICH IS GAMMA-SYNUCLEINOPATHY | 2018 |
|
RU2703430C1 |
| METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
| METHOD FOR DETECTING AN ACTIVE DESTRUCTIVE PROCESS IN THE RETINA IN AN EXPERIMENT | 2021 |
|
RU2768588C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| AGENT FOR REDUCING INTRAOCULAR PRESSURE AND METHOD OF USE THEREOF | 2022 |
|
RU2815996C1 |
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
| METHOD OF TREATING OCCLUSION OF CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2015 |
|
RU2603318C1 |
| METHOD OF DIAGNOSTICS OF INITIAL JUXTAPAPILLARY CAPILLARY HEMANGIOMA OF RETINA | 2018 |
|
RU2668701C1 |
